Quick answers
- Is CVE-2026-9614 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-9614 being exploited in the wild.
- How severe is CVE-2026-9614?
- High severity, with a CVSS score of 8.8, published 1 June 2026.
- Which products and versions are affected?
- Ivanti Neurons for ITSM Cloud and On-Premises versions.
- Is there a fix for CVE-2026-9614?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-9614 attacked?
- It is attacked over the network, in a hosted service.
- Am I affected by CVE-2026-9614?
- Check whether you run Ivanti Neurons for ITSM at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
An Improper Access Control vulnerability (CWE-284) exists in Ivanti Neurons for ITSM affecting both cloud and on-premises deployments. The flaw allows a remote attacker with low-privileged authenticated access to bypass intended authorization constraints and escalate their privileges to administrative levels. The attack is network-reachable and requires no user interaction. Successful exploitation grants the attacker full control over the ITSM environment, including the ability to access, modify, or delete sensitive data and configurations. Ivanti has released a security advisory to address this issue.
Affected products
- Ivanti Neurons for ITSM Cloud and On-Premises versions
Timeline
- 2026-06-01: disclosed
- 2026-06-01: advisory